Health
FDA Authorizes Marketing of First Device that Uses Artificial Intelligence to Help Detect Potential Signs of Colon Cancer – FDA.gov
FDA authorized marketing of the first device that uses artificial intelligence to detect lesions in the colon during a colonoscopy.
For Immediate Release:
April 09, 2021
Today, the U.S. Food and Drug Administration authorized marketing of the GI Genius, the first device that uses artificial intelligence (AI) based on machine learning to assist clinicians in detecting lesions (such as polyps or suspected tumors) in the colon in real time during a colonoscopy.
Artificial intelligence has the potential to transform health care to better assist health care providers and improve patient care. When AI is combined with traditional…
-
Noosa News21 hours agoMan dies after stabbing in inner-city unit
-
Noosa News24 hours agoThe Almond Ashes sees Australia and India mix business and cricket
-
General24 hours agoUK PM ready to ‘shelter’ businesses from tariff storm
-
General24 hours agoWhy do states and territories have different school holidays?